Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/178876
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Decreased CX3CL1 levels in the cerebrospinal fluid of patients with Alzheimer's disease |
Autor: | Perea, Juan Ramón; Lleó, Alberto; Alcolea, Daniel; Fortea, Juan; Ávila, Jesús CSIC ORCID ; Bolós, Marta CSIC ORCID | Palabras clave: | Inflammation Human CSF Microglia CX3CL1 Alzheimer’s disease Tau |
Fecha de publicación: | 7-sep-2018 | Citación: | Frontiers in Neuroscience 12 (2018) | Resumen: | Alzheimer's disease (AD) is a neurodegenerative disease characterized by the presence of neurofibrillary tangles, constituted by tau protein, and plaques formed by amyloid-beta protein. The disease courses with high neural damage, which leads to memory loss and death. Here we analyzed the presence of CX3CL1, a chemokine expressed by neurons, in cerebrospinal fluid (CSF) samples from control subjects and patients with mild cognitive impairment and AD dementia. CX3CL1 was decreased in the CSF of AD dementia patients compared to control subjects. However, there was not difference in plasma samples from the same subjects. | URI: | http://hdl.handle.net/10261/178876 | DOI: | 10.3389/fnins.2018.00609 | Identificadores: | doi: 10.3389/fnins.2018.00609 issn: 1662-453X |
Aparece en las colecciones: | (CBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
BolosM_DecreasedCX3CL1Level.pdf | 214,13 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
30
checked on 05-mar-2024
SCOPUSTM
Citations
42
checked on 16-mar-2024
WEB OF SCIENCETM
Citations
41
checked on 29-feb-2024
Page view(s)
203
checked on 19-mar-2024
Download(s)
158
checked on 19-mar-2024